Despite the limitation of the study related to the particularity of biological samples that constrains the number of subjects, to our knowledge this is the first study revealing the gene expression profile of BM-derived CD34+ HSPCs from CAD patients who are distinguished by the only presence of T2DM. This evidence concerns the gene CD34 and type 2 diabetes mellitus.